Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma

Fig. 1

Probabilities of intracranial control (left) and overall survival among patients receiving a standard radiation dose (60 Gy radiotherapy [RT]) and those receiving dose-escalated radiotherapy (66 Gy RT). Median time to intracranial relapse: 225 days (60 Gy) versus 289 days (66 Gy), p = 0.011. Median OS: 397 days (60 Gy) versus 533 days (66 Gy), p = 0.012

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us